MONICA THOMAS: Open Payments
NPI 1124661954 · ALEXANDER CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 41 payments from 16 companies in 2025. Trend: 2023 $54 · 2024 $959 · 2025 $936
Food & beverage: $761Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $307 |
| Amgen Inc. | 1 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $116 |
| Novo Nordisk Inc | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Exact Sciences Corporation | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $21 |
| SCILEX PHARMACEUTICALS INC. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: REXULTI, PROLIA, CAPLYTA, Ozempic, BREZTRI, Cologuard Collection Kit, Auvelity, Rybelsus.
Industry payments across AL — which companies pay providers there.
